Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

High-voltage lead performance study shows positive results

St Jude Medical : 16 May, 2008  (Company News)
St Jude Medical has announced the results from the largest actively monitored, multi-site lead performance evaluation ever conducted for an ICD lead family.
The data presented is from an analysis of four prospective studies, all with comprehensive data monitoring on the performance of the Riata lead family. The analysis concluded that performance and reliability of Riata leads are excellent, based on data collected from more than 680 physicians at more than 370 sites.

The studies analysed the experience of 7,498 patients who were implanted with Riata leads as part of their implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT-D) systems.

All sites participating in the four studies (ACT, OPTIMUM, RHYTHM and PAS; see below for a description of the studies) were monitored. To ensure the data were as accurate as possible, each patient's source records were individually reviewed to be certain that all lead-related complications (further sub-categorized as fracture, insulation damage, perforation or dislodgment) were reported.

The data showed that adverse event rates for all categories of lead-related complications were very low. Overall, the Riata leads' fracture rates were 0.09 percent (9 in 10,000), insulation damage rates were 0.13 percent (13 in 10,000, with no insulation failures exhibited in Riata leads utilising Optim insulation), perforation rates were 0.31 percent (31 in 10,000), and dislodgement rates were 0.88 percent (88 in 10,000). These adverse events rates are significantly lower than many previously reported rates in the medical literature on ICD leads.

The results are believed to be the largest and broadest analysis of lead-related complications ever to be presented, especially with complete data monitoring, and unlike reports of single-centre experiences or case reports, should best represent real-world experience in a wide range of implanter's hands.

The results from these studies are particularly significant given the duration of follow-up, which was a median of 22 months for the four studies.

'St Jude Medical is openly sharing this data so that physicians have better information upon which to make informed decisions in choosing a defibrillation lead, as well as information that may help to reduce the risks inherent in any medical procedure,' said Eric S Fain, MD, president of the St Jude Medical Cardiac Rhythm Management Division. 'We are committed to closely and continuously tracking the performance of our products so that physicians have reliable information that will lead to better care for their patients.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo